Related Experiment Video

Updated: Sep 21, 2025

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.4K

Stem Cells and Congenital Heart Disease: The Future Potential Clinical Therapy Beyond Current Treatment

Katherine Julian1, Nikita Garg2, Narutoshi Hibino3

  • 1Penn State College of Medicine, Hershey, Pennsylvania, USA.

Current Cardiology Reviews
|June 1, 2022
PubMed

Insights

Stem cells offer promising new treatments for congenital heart disease (CHD), a common birth defect. Research is exploring their use in modeling and treating CHD, particularly hypoplastic left heart syndrome.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Pediatric Cardiology

Background:

  • Congenital heart disease (CHD) is the most frequent congenital anomaly in newborns.
  • Current treatments for cyanotic CHD primarily involve surgical interventions, yet significant morbidity and mortality persist.
  • Existing therapeutic strategies for CHD have limitations, necessitating novel approaches.

Purpose of the Study:

  • To review the current applications of stem cells in congenital heart disease (CHD) research and treatment.
  • To explore the potential of stem cells for modeling CHD.
  • To discuss future directions for stem cell-based therapies in managing CHD.

Main Methods:

  • Literature review of recent studies on stem cell applications in CHD.
  • Analysis of stem cell-based disease modeling techniques for CHD.
  • Examination of clinical trials and preclinical research involving stem cells for CHD treatment.

Main Results:

  • Stem cells are being utilized to create models of CHD, aiding in understanding disease mechanisms.
  • Early-stage research indicates potential for stem cells in treating specific CHD conditions, notably hypoplastic left heart syndrome.
  • The therapeutic efficacy and safety of stem cells for various CHD types are under active investigation.

Conclusions:

  • Stem cell therapy represents a promising frontier in the management of congenital heart disease.
  • Further research is crucial to optimize stem cell-based treatments and overcome current therapeutic challenges in CHD.
  • The future of CHD treatment may involve regenerative approaches leveraging stem cell potential.

Keywords:
Stem cellcardiologycongenital heart diseasehypoplastic left heartregenerative medicinetissue engineering

More Related Videos

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

6.7K
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

7.9K

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.4K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
29.1K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.5K